Annual FCF
-$69.73 M
-$21.88 M-45.74%
December 31, 2022
Summary
- As of February 8, 2025, AMAM annual free cash flow is -$69.73 million, with the most recent change of -$21.88 million (-45.74%) on December 31, 2022.
- During the last 3 years, AMAM annual FCF has fallen by -$66.92 million (-2378.81%).
Performance
AMAM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$19.18 M
-$5.24 M-37.62%
September 1, 2023
Summary
- As of February 8, 2025, AMAM quarterly free cash flow is -$19.18 million, with the most recent change of -$5.24 million (-37.62%) on September 1, 2023.
- Over the past year, AMAM quarterly FCF has dropped by -$3.29 million (-20.74%).
Performance
AMAM Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$58.83 M
-$3.29 M-5.93%
September 1, 2023
Summary
- As of February 8, 2025, AMAM TTM free cash flow is -$58.83 million, with the most recent change of -$3.29 million (-5.93%) on September 1, 2023.
- Over the past year, AMAM TTM FCF has dropped by -$1.85 million (-3.24%).
Performance
AMAM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AMAM Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -45.7% | -20.7% | -3.2% |
| 3 y3 years | -2378.8% | - | - |
| 5 y5 years | -2378.8% | - | - |
AMAM Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +45.7% | at low | +50.4% | +37.9% | +122.5% | +18.5% |
| 5 y | 5-year | +2378.8% | at low | +50.4% | +37.9% | +122.5% | +18.5% |
| alltime | all time | +2378.8% | at low | +50.4% | +37.9% | +122.5% | +18.5% |
Ambrx Biopharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$19.18 M(+37.6%) | -$58.83 M(+5.9%) |
| Jun 2023 | - | -$13.93 M(+7.4%) | -$55.53 M(-1.3%) |
| Mar 2023 | - | -$12.97 M(+1.7%) | -$56.26 M(-19.3%) |
| Dec 2022 | -$69.73 M | -$12.75 M(-19.7%) | -$69.73 M(+22.4%) |
| Sep 2022 | - | -$15.88 M(+8.3%) | -$56.98 M(+38.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$14.66 M(-44.5%) | -$41.10 M(+55.5%) |
| Mar 2022 | - | -$26.44 M | -$26.44 M |
| Dec 2021 | -$47.85 M(+129.7%) | - | - |
| Dec 2020 | -$20.83 M(+640.4%) | - | - |
| Dec 2019 | -$2.81 M | - | - |
FAQ
- What is Ambrx Biopharma annual free cash flow?
- What is the all time high annual FCF for Ambrx Biopharma?
- What is Ambrx Biopharma annual FCF year-on-year change?
- What is Ambrx Biopharma quarterly free cash flow?
- What is the all time high quarterly FCF for Ambrx Biopharma?
- What is Ambrx Biopharma quarterly FCF year-on-year change?
- What is Ambrx Biopharma TTM free cash flow?
- What is the all time high TTM FCF for Ambrx Biopharma?
- What is Ambrx Biopharma TTM FCF year-on-year change?
What is Ambrx Biopharma annual free cash flow?
The current annual FCF of AMAM is -$69.73 M
What is the all time high annual FCF for Ambrx Biopharma?
Ambrx Biopharma all-time high annual free cash flow is -$2.81 M
What is Ambrx Biopharma annual FCF year-on-year change?
Over the past year, AMAM annual free cash flow has changed by -$21.88 M (-45.74%)
What is Ambrx Biopharma quarterly free cash flow?
The current quarterly FCF of AMAM is -$19.18 M
What is the all time high quarterly FCF for Ambrx Biopharma?
Ambrx Biopharma all-time high quarterly free cash flow is -$12.75 M
What is Ambrx Biopharma quarterly FCF year-on-year change?
Over the past year, AMAM quarterly free cash flow has changed by -$3.29 M (-20.74%)
What is Ambrx Biopharma TTM free cash flow?
The current TTM FCF of AMAM is -$58.83 M
What is the all time high TTM FCF for Ambrx Biopharma?
Ambrx Biopharma all-time high TTM free cash flow is -$26.44 M
What is Ambrx Biopharma TTM FCF year-on-year change?
Over the past year, AMAM TTM free cash flow has changed by -$1.85 M (-3.24%)